Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil pre-injection dose-ranging study for prevention of sufentanil-induced cough during general anesthesia induction
ChiCTR2000029324Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remifentanil in cough (6 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Coughing times. Started Feb 2020; status: recruiting.
02
Drugs
remifentanil
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR2000029324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029324.